91 related articles for article (PubMed ID: 16109604)
41. Expression of cyclin genes in human gastric cancer and in first degree relatives.
Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
[TBL] [Abstract][Full Text] [Related]
42. Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma/chronic lymphocytic leukaemia.
Teixeira Mendes LS; Peters N; Attygalle AD; Wotherspoon A
J Clin Pathol; 2017 Oct; 70(10):899-902. PubMed ID: 28408436
[TBL] [Abstract][Full Text] [Related]
43. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
44. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
45. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
[TBL] [Abstract][Full Text] [Related]
46. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
47. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.
Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X
Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560
[No Abstract] [Full Text] [Related]
48. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
[TBL] [Abstract][Full Text] [Related]
49. Expression of cyclins and cdks throughout murine carcinogenesis.
Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
[TBL] [Abstract][Full Text] [Related]
50. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
51. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells.
Mori N; Fujii M; Hinz M; Nakayama K; Yamada Y; Ikeda S; Yamasaki Y; Kashanchi F; Tanaka Y; Tomonaga M; Yamamoto N
Int J Cancer; 2002 May; 99(3):378-85. PubMed ID: 11992406
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
53. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1998 Aug; 17(8):1027-37. PubMed ID: 9747882
[TBL] [Abstract][Full Text] [Related]
54. D cyclins in lymphocytes.
Kaplan D; Meyerson H; Husel W; Lewandowska K; MacLennan G
Cytometry A; 2005; 63(1):1-9. PubMed ID: 15619730
[TBL] [Abstract][Full Text] [Related]
55. Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase.
Obermann EC; Went P; Tzankov A; Pileri SA; Hofstaedter F; Marienhagen J; Stoehr R; Dirnhofer S
J Clin Pathol; 2007 Jul; 60(7):794-7. PubMed ID: 16950856
[TBL] [Abstract][Full Text] [Related]
56. Cyclin D1 expression in typical chronic lymphocytic leukaemia.
Abboudi Z; Patel K; Naresh KN
Eur J Haematol; 2009 Sep; 83(3):203-7. PubMed ID: 19467018
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.
Ko TC; Sheng HM; Reisman D; Thompson EA; Beauchamp RD
Oncogene; 1995 Jan; 10(1):177-84. PubMed ID: 7824270
[TBL] [Abstract][Full Text] [Related]
59. A small deletion in the 3'-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia.
Hosokawa Y; Suzuki R; Joh T; Maeda Y; Nakamura S; Kodera Y; Arnold A; Seto M
Int J Cancer; 1998 Jun; 76(6):791-6. PubMed ID: 9626342
[TBL] [Abstract][Full Text] [Related]
60. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
Yang WI; Zukerberg LR; Motokura T; Arnold A; Harris NL
Am J Pathol; 1994 Jul; 145(1):86-96. PubMed ID: 7518196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]